Diagnosing China's impact on patients, policy and the future of all of our health.
The go-to briefing for consultants, investors and decision-makers in biopharma, medtech and global health.
Interactions between geopolitics and technology have never been more frequent and impactful than in this era. The newsletter focuses on the phenomenon and introduces interesting things about China's tech governance and its competition with the West.
Now the decline of this niche has driven out everybody else I can be on it. I am doing this also because my generalist editor will filter technicalities out.
Covering the priorities of both the leadership and the general public in China and views you do not normally see from mainstream English-language media